Mitchell E. Levinson - 15 Nov 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Chief Strategy Officer
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
15 Nov 2023
Net transactions value
+$105,090
Form type
4
Filing time
17 Nov 2023, 09:10:09 UTC
Previous filing
03 Nov 2023
Next filing
08 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $2,689 +461 +0.67% $5.83 69,227 15 Nov 2023 Direct
transaction PLSE Common Stock Purchase $22,344 +3,800 +5.5% $5.88 73,027 15 Nov 2023 Direct
transaction PLSE Common Stock Purchase $29,700 +5,000 +121% $5.94 9,135 15 Nov 2023 Spouse
transaction PLSE Common Stock Purchase $1,184 +200 +27% $5.92 934 15 Nov 2023 Immediate Family Member (1)
transaction PLSE Common Stock Purchase $13,662 +2,300 +246% $5.94 3,234 15 Nov 2023 Immediate Family Member (1)
transaction PLSE Common Stock Purchase $594 +100 +14% $5.94 834 15 Nov 2023 Immediate Family Member (2)
transaction PLSE Common Stock Purchase $14,030 +2,400 +288% $5.85 3,234 15 Nov 2023 Immediate Family Member (2)
transaction PLSE Common Stock Purchase $590 +100 +14% $5.90 834 15 Nov 2023 Immediate Family Member (3)
transaction PLSE Common Stock Purchase $13,926 +2,400 +288% $5.80 3,234 15 Nov 2023 Immediate Family Member (3)
transaction PLSE Common Stock Purchase $6,372 +1,039 $6.13 1,039 15 Nov 2023 Immediate family member (4)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.